Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1984 • 6,841 citations

Cell Death

2004 • 4,599 citations

Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis

1998 • 4,383 citations

Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

2001 • 3,867 citations

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

2005 • 3,292 citations

Treatment of Acute Lymphoblastic Leukemia

2006 • 1,937 citations

Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics

2002 • 1,617 citations

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

2006 • 1,214 citations

Bim: a novel member of the Bcl-2 family that promotes apoptosis

1998 • 1,154 citations

Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane

2000 • 1,150 citations

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

2006 • 993 citations

Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.

1993 • 855 citations

Acute Lymphoblastic Leukemia

1998 • 816 citations

14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain Phosphorylation

2000 • 634 citations

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

2006 • 512 citations

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

2006 • 473 citations

Short tandem repeat profiling provides an international reference standard for human cell lines

2001 • 459 citations

Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy

1998 • 449 citations

Use of ?-asparaginase in childhood ALL

1998 • 439 citations

Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1996 • 424 citations

Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1996 • 419 citations

Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive Inhibitors

2005 • 416 citations

Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics

1985 • 331 citations

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995

2000 • 322 citations

Survival after relapse in childhood acute lymphoblastic leukemia

1998 • 292 citations

Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group

1991 • 276 citations

In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia

1997 • 266 citations

Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies

2004 • 234 citations

Childhood acute lymphoblastic leukaemia and relapse

2005 • 219 citations

Killing cancer cells by flipping the Bcl-2/Bax switch

2005 • 210 citations

The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse

2002 • 200 citations

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.

1983 • 192 citations

Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein

2002 • 192 citations

Heterodimerization-independent Functions of Cell Death Regulatory Proteins Bax and Bcl-2 in Yeast and Mammalian Cells

1997 • 171 citations

Long‐term follow‐up of relapsed childhood acute lymphoblastic leukaemia

2003 • 154 citations

A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation

1996 • 153 citations

Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study

2000 • 147 citations

Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells

2001 • 142 citations

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

1997 • 138 citations

Pharmacological manipulation of Bcl-2 family members to control cell death

2005 • 134 citations

Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells

2001 • 126 citations

Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers

1998 • 121 citations

Asparaginase Pharmacokinetics After Intensive Polyethylene Glycol-Conjugated L-Asparaginase Therapy for Children with Relapsed Acute Lymphoblastic Leukemia

2004 • 106 citations

A Genome-Wide View of the In vitro Response to <scp>l</scp>-Asparaginase in Acute Lymphoblastic Leukemia

2005 • 102 citations

The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer

1982 • 97 citations

A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations

2007 • 96 citations

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

1998 • 89 citations

Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia

2003 • 87 citations

Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation

1991 • 86 citations

N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes

2002 • 83 citations

Caspase-8 and apoptosis-inducing factor mediate a cytochrome c-independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin.

2003 • 81 citations

Bid induces cytochrome c-impermeable Bax channels in liposomes

2002 • 68 citations

Outcome after first relapse in children with acute lymphoblastic leukemia: A population‐based study of 315 patients from the nordic society of pediatric hematology and oncology (NOPHO)

1995 • 67 citations

DIMSCAN: A Microcomputer Fluorescence-Based Cytotoxicity Assay for Preclinical Testing of Combination Chemotherapy

2005 • 65 citations

Prognostic Significance of Early Response to a Single Dose of Asparaginase in Childhood Acute Lymphoblastic Leukemia

1999 • 62 citations

Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study

1988 • 60 citations

The pharmacokinetics of single high doses of dexamethasone in cancer patients

1987 • 59 citations

Bid induces cytochrome c-impermeable Bax channels in liposomes

2002 • 55 citations

Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis

1999 • 54 citations

Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: A Children's Oncology Group study (CCG‐1941)

2006 • 54 citations

Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients

2006 • 51 citations

Asparagine synthetase activity in paediatric acute leukaemias: AML‐M5 subtype shows lowest activity

2000 • 50 citations

Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.

2005 • 50 citations

BH3‐only proteins: Integrated control point of apoptosis

2006 • 50 citations

BCL-2: found bound and drugged!

2005 • 47 citations

Apoptosis of human myeloid leukemia cells induced by an inhibitor of protein phosphatases (okadaic acid) is prevented by Bcl-2 and Bcl-XL

1997 • 45 citations

Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix.

1997 • 41 citations

Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia

2005 • 35 citations

Pharmacokinetics and drug monitoring of L-asparaginase treatment.

1997 • 33 citations

In Vitro Testing of Chemosensitivity in Physiological Hypoxia

2005 • 23 citations

Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli‐asparaginase or Erwinia‐asparaginase in childhood acute lymphoblastic leukemia (ALL)

2005 • 17 citations

Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia

2003 • 15 citations

The Children Leukemia Group

2002 • 14 citations

Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia

1998 • 10 citations

Minimal Residual Disease Untersuchungen bei der akuten lymphatischen Leukämie im Kindesalter im Rahmen der COALL-Studie: Ergebnisse einer Induktionstherapie ohne Asparaginase

2000 • 7 citations